CIK 0001048477
- Large accelerated filer
BIOMARIN PHARMACEUTICAL INC
Sign in to watch- Ticker
- BMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680397820
- Phone
- +1 415-506-6700
- Business address
- 105 DIGITAL DRIVE, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,163,748
- in 1 filing
Net −$1,163,748. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-02 | Mueller Brian EVP, Chief Financial Officer | Exercise or conversion · Stock Option (Right to buy Common Stock) | −2,139 | 0 | ||
| 2022-12-02 | Mueller Brian EVP, Chief Financial Officer | Exercise or conversion · Stock Option (Right to buy Common Stock) | −3,761 | 0 | ||
| 2022-12-02 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale | −471 | $103.97 | $49K | 322,453 |
| 2022-12-02 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale | −600 | $103.97 | $62K | 321,853 |
| 2022-12-02 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale | −260 | $103.98 | $27K | 321,593 |
| 2022-12-02 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale | −100 | $104.00 | $10K | 321,493 |
| 2022-12-02 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale | −69 | $104.06 | $7K | 321,424 |
| 2022-11-23 | Mueller Brian EVP, Chief Financial Officer | Sale | −934 | $95.09 | $89K | 29,792 |
| 2022-11-23 | Mueller Brian EVP, Chief Financial Officer | Sale | −945 | $99.50 | $94K | 28,847 |
| 2022-11-23 | Mueller Brian EVP, Chief Financial Officer | Exercise or conversion | +3,500 | $67.81 | $237K | 32,347 |
| 2022-11-23 | Mueller Brian EVP, Chief Financial Officer | Sale | −3,500 | $99.50 | $348K | 28,847 |
| 2022-11-23 | Mueller Brian EVP, Chief Financial Officer | Exercise or conversion · Stock Option (Right to buy Common Stock) | −3,500 | 3,761 | ||
| 2022-11-02 | BIENAIME JEAN JACQUES Chief Executive Officer | Other acquisition | +100 | $86.12 | $9K | 322,924 |
| 2022-11-02 | Ajer Jeffrey Robert EVP, Chief Commercial Officer | Sale | −3,000 | $86.12 | $258K | 41,088 |
| 2022-10-31 | Alles Mark J Director | Purchase | +3,625 | $86.75 | $314K | 10,905 |
| 2022-10-31 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale | −1,500 | $86.55 | $130K | 322,824 |
| 2022-10-14 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale | −4,000 | $89.89 | $360K | 324,324 |
| 2022-08-15 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale | −3,000 | $95.21 | $286K | 328,324 |
| 2022-08-12 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale | −4,000 | $94.75 | $379K | 331,324 |
| 2022-08-11 | Ajer Jeffrey Robert EVP, Chief Commercial Officer | Sale | −3,000 | $95.62 | $287K | 44,088 |
Page 20 of 23 · 450 trades